Related references
Note: Only part of the references are listed.Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study
Chuck T. Chen et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Essential Role of the Redox-Sensitive Kinase p66shc in Determining Energetic and Oxidative Status and Cell Fate in Neuronal Preconditioning
Jacquelynn E. Brown et al.
JOURNAL OF NEUROSCIENCE (2010)
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
Yasushi Saito et al.
ATHEROSCLEROSIS (2008)
Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid
Joshua D. Brooks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the ω-3 polyunsaturated fatty acid docosahexaenoic acid
Erik S. Musiek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
Philip C. Calder
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Fetal mechanisms in neurodevelopmental disorders
Susan L. Connors et al.
PEDIATRIC NEUROLOGY (2008)
Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation
Valerie Ferreira et al.
ATHEROSCLEROSIS (2007)
n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARγ activation in human keratinocyte HaCaT cells
Gerald Chene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3
Ling Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
NF-κB activation by reactive oxygen species:: Fifteen years later
Geoffrey Gloire et al.
BIOCHEMICAL PHARMACOLOGY (2006)
In vivo and in vitro lipid peroxidation of arachidonate esters:: The effect of fish oil ω-3 lipids on product distribution
Todd A. Davis et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Use of fish oil in parenteral nutrition: rationale and reality
Philip C. Calder
PROCEEDINGS OF THE NUTRITION SOCIETY (2006)
Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid
Ling Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Polyunsaturated eicosapentaenoic acid changes lipid composition in lipid rafts
QR Li et al.
EUROPEAN JOURNAL OF NUTRITION (2006)
Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders
John W. Phillis et al.
BRAIN RESEARCH REVIEWS (2006)
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE
JGF Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages
ES Musiek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nuclear factor κB signaling in atherogenesis
MPJ de Winther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells:: Evidence for a PPAR-γ-dependent mechanism
H Li et al.
KIDNEY INTERNATIONAL (2005)
Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases
KS Montine et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2004)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention
KS Chun et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Oxidized omega-3 fatty acids inhibit NF-κB activation via a PPARα-dependent pathway
A Mishra et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Lipoxygenase pathways in atherogenesis
L Zhao et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
The cyclopentenone product of lipid peroxidation, 15-A(2t)-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione
GL Milne et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Oxidized omega-3 fatty acids inhibit pro-inflammatory responses in glomerular endothelial cells
A Chaudhary et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: Rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS)
M Yokoyama et al.
AMERICAN HEART JOURNAL (2003)
Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids
JY Lee et al.
JOURNAL OF LIPID RESEARCH (2003)
Caspase 3 activation is essential for neuroprotection in preconditioning
B McLaughlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Omega-3 fatty acids in inflammation and autoimmune diseases
AP Simopoulos
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2002)
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
PM Kris-Etherton et al.
CIRCULATION (2002)
Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid
SS Fam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages
JC Vallvé et al.
ATHEROSCLEROSIS (2002)
Prostaglandins and other lipid mediators in Alzheimer's disease
NG Bazan et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
First total synthesis of A2 isoprostane
G Zanoni et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
ME Burleigh et al.
CIRCULATION (2002)
n-3 fatty acids: Antiatherosclerotic effects
R De Caterina et al.
LIPIDS (2001)
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
A Chawla et al.
NATURE MEDICINE (2001)
Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation
TS Blackwell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
A Rossi et al.
NATURE (2000)
Activated nuclear factor-kappa B is present in the coronary vasculature in experimental hypercholesterolemia
SH Wilson et al.
ATHEROSCLEROSIS (2000)
Share Paper
